Jamie Holmes says a surgery center tried to make her pay for two operations after she underwent only one. She refused to buckle, even after a collection agency sued her last winter.
Seelos’ stock plunges by over 75% after ketamine drug for suicide prevention fails a PhII trial
Seelos Therapeutics’ intranasal racemic ketamine candidate has missed the primary endpoint in a Phase II trial of major depressive disorder patients with acute suicidal ideation,